NERVE ABLATION SYSTEM MARKET

INTRODUCTION

Innovative medical technologies called nerve ablation systems selectively disable or kill particular nerves in the body to address disorders associated with persistent pain. Nerve ablation, also known as neurolysis, is a minimally invasive surgery that tries to stop the transmission of pain signals and offers long-term comfort to patients who have not experienced relief from conventional pain management techniques.

An image-guiding system, a customized probe, and a radiofrequency generator are the three major parts of a standard nerve ablation system. High-frequency electrical currents are generated by the radiofrequency generator and transmitted to the targeted nerve through the probe.

Under the supervision of imaging methods like fluoroscopy or ultrasound, the probe, which is often a thin needle or catheter, is placed close to the nerve. The risk of damaging nearby tissues is reduced thanks to imaging guidance, which guarantees exact needle placement.

Radiofrequency radiation is administered to the nerve after the probe is in place, producing heat and leading to regional thermal ablation. The disruption of the pain signals caused by this carefully monitored destruction of the nerve tissue can significantly relieve patients' suffering. The ablation technique can be repeated if necessary and is normally done without hospitalization.

Systems for cutting nerves can be performed using radiofrequency ablation (RFA), cryoablation, or chemical neurolysis. The most widely utilized method, radiofrequency amplification (RFA), uses heat produced by radiofrequency energy. On the other hand, cryoablation uses extremely low temperatures to freeze and kill nerve tissue.

Chemical neurolysis entails infusing a neurolytic substance into the nerve to cause chemical ablation, such as alcohol or phenol.Numerous chronic pain problems, including as arthritis, back pain, neck pain, neuropathy, and cancer-related pain, are treated with nerve ablation devices.

They provide a substitute for more intrusive procedures, including surgery, and they can relieve pain without the need for chronic medication. Patients who have not improved after receiving conventional therapies including drugs, physical therapy, or nerve blocks benefit most from nerve ablation.

The capacity of nerve ablation devices to deliver long-lasting pain relief is one of their key benefits. The stoppage of pain signals, which can continue for several months to years but does not permanently harm the nerves, allows patients to noticeably improve their quality of life. Additionally, nerve ablation operations often have low risks and consequences and are well tolerated.

It is crucial to remember that not all people or pain conditions are candidates for nerve ablation. The method necessitates cautious patient selection because it could not work for all forms of pain or in situations where the nerves gradually regrow.

Additionally, there could be hazards, just as with any medical procedure, such as infection, hemorrhage, nerve damage, or allergic responses to the local anesthetic.

In summary, nerve ablation systems are cutting-edge medical technologies that provide a less invasive method of treating problems associated with chronic pain. These devices can offer patients who have not reacted favorably to conventional treatments long-lasting pain relief by selectively inhibiting or killing particular nerves.

Although nerve ablation has its drawbacks and potential hazards, it is nevertheless a useful alternative for managing pain and enhancing the lives of those who experience chronic pain. In summary, nerve ablation systems are cutting-edge medical technologies that provide a less invasive method of treating problems associated with chronic pain. 

NERVE ABLATION SYSTEM MARKET SIZE AND FORECAST

The Global Nerve Ablation System Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

NERVE ABLATION SYSTEM MARKET NEW PRODUCT LAUNCH

IonicRFTM Generator, a new device recently approved by the U.S. Food and Drug Administration to administer a non-surgical, minimally invasive treatment for the management of pain in the nervous system, was launched today by Abbott (NYSE: ABT). A radiofrequency ablation tool called the IonicRF Generator utilizes heat to target particular nerves and prevent pain signals from reaching the brain.

The new gadget, which has already received approval in the US and Europe, is the first RF ablation device created by Abbott. In order to prevent a small patch of nerve tissue from continuing to generate pain signals, radiofrequency ablation uses an electric current to burn it up.

According to studies, the pain reduction experienced after a single radiofrequency ablation treatment might continue anywhere between six and twelve months.Low back pain is one of the most prevalent medical complaints in the world, and radiofrequency ablation therapy is frequently used to treat facet joint syndrome, which is thought to account for 15% of these symptoms.

When traditional therapies like physical therapy, injections, or medication failed to relieve discomforts, such as low back pain and sacroiliac joint (buttocks) pain, radiofrequency ablation was used.Chronic pain can have a negative effect on a person's daily routine, work productivity, and interpersonal connections.

The radiofrequency therapy and spinal cord stimulation therapy products offered by Abbott, a world leader in the development of chronic pain therapy solutions, include radiofrequency ablation generators and accessories, BurstDRTM stimulation, and dorsal root ganglion stimulation.

NERVE ABLATION SYSTEM MARKET COMPANY PROFILES

• Medtronic Plc
• Johnson & Johnson
• Abbott Laboratories
• Smith & Nephew Plc
• Boston Scientific Corporation
• Avanos Medical Inc
• RF Medical Co. Ltd
•  AngioDynamics Inc
• AtriCure Inc
• Stryker Corporation

THIS NERVE ABLATION SYSTEM MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Nerve Ablation Systems are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost Breakup of a Global Nerve Ablation System and key vendor selection criteria
3. Where is the Nerve Ablation System manufactured? What is the average margin per unit?
4. Market share of Global Nerve Ablation System market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Nerve Ablation System in-house
6. key predictions for next 5 years in the Global Nerve Ablation System market
7. Average B-2-B Nerve Ablation System market price in all segments
8. Latest trends in the Nerve Ablation System market, by every market segment
9. The market size (both volume and value) of the Nerve Ablation System market in 2024-2030 and every year in between?
10. Production breakup of the Nerve Ablation System market, by suppliers and their OEM relationship